FDA 483 OBSERVATION · #32 OF 1,945 MOST-CITED

Critical limits

FDA cited this observation 667 times across 584 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods667
BY FISCAL YEAR
FY20273
FY202646
FY202540
FY202436
FY202357
FY202246
FY202121
FY202049
FY2019105
FY201877
FY2017102
FY201685

What this observation means, and how to comply

SPEQ's practitioner reading of this finding. The regulatory basis is a cited fact; the interpretation, compliance steps, and root causes are SPEQ synthesis — not an FDA classification of the citation.

Seafood 21 CFR 123.6(c)(3) · Juice 21 CFR 120.8

The HACCP plan did not set adequate critical limits at its critical control points, or the limits set were not validated to control the hazard — so monitoring the CCP would not actually assure control.

Why FDA writes it — A critical limit is the line between safe and unsafe at a control point. If it is missing, wrong, or not validated, the CCP monitors against a meaningless value and the hazard can pass through controlled-on-paper but not in reality.

HOW TO COMPLY
  • Set a critical limit at each critical control point that is scientifically validated to control the identified hazard (e.g., time/temperature for a lethality step).
  • Base the limit on scientific or regulatory support, and be able to justify it.
  • Define how conformance to the limit is measured and monitored.
  • Revalidate critical limits when the process, product, or supporting science changes.
WHY FIRMS GET CITED
  • Critical limits copied from a generic model without validating them for the specific process.
  • Limits set to what the process happens to achieve rather than to what controls the hazard.
PROFESSIONAL · REMEDIATION PLAYBOOK · SPEQ SYNTHESIS

How to close this finding — and stop it recurring

CHECKING ACCESS

Checking your access…

What this observation is associated with

Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 1.7× the rate of the average FDA-cited firm (13.0% vs 7.8%), across 584 FEI-matched firms.

This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.

CHECKING ACCESS

Checking your access…

How FDA worded it — real examples

Your HACCP plan lists a critical limit that does not ensure control of one or more hazards.

L & R Fine Food, Inc. · Garden Grove, California · Foods · 2026-10-13

Your HACCP plan lists a critical limit that does not ensure control of one or more hazards.

Usarg, Inc · Miami, Florida · Foods · 2026-10-09

Your HACCP plan does not list a critical limit that ensures control of one or more hazards and lists a critical limit that does not ensure control of one or more hazards.

DPB Holdings, Inc · Brighton, Colorado · Foods · 2026-10-09

Your HACCP plan lists a critical limit that does not ensure control of one or more hazards.

Lemonland Food Corp · Kent, Washington · Foods · 2026-09-30

Your HACCP plan lists a critical limit that does not ensure control of one or more hazards.

True Grade, LLC. · Miami, Florida · Foods · 2026-09-18

Your HACCP plan lists a critical limit that does not ensure control of one or more hazards.

True Grade · Miami, Florida · Foods · 2026-09-18

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

HACCP →Food industry →

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →